Company Overview of Moderna Therapeutics, Inc.
Moderna Therapeutics, Inc. develops messenger RNA therapeutics. The company provides in vivo drug modality that produces human proteins or antibodies inside patient cells. It also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. The company focuses on disease areas, such as inherited genetic disorders, hemophilic and blood factors, and oncology. Moderna Therapeutics, Inc. has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals, Inc. The company was incorporated in 2009 and is based in Cambridge, Massachusetts.
200 Tech Square
Cambridge, MA 02139
Founded in 2009
Key Executives for Moderna Therapeutics, Inc.
Moderna Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Audentes Therapeutics, Inc.||United States|
|DUSA Pharmaceuticals Inc.||United States|
|BSF AG Research Inc.||United States|
|Thomas M.Teague Biotechnology Center of Maine||United States|
|ProteinTech Group Inc.||United States|
Recent Private Companies Transactions
January 13, 2014
November 6, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- New York City, NY | BloombergPosted: Apr 14
- Delaware | DuPontPosted: Apr 11
- Gaithersburg, MD | MedimmunePosted: Apr 16
- New York | Shore ConsultantsPosted: Apr 14
Sponsored Financial Commentaries
To contact Moderna Therapeutics, Inc., please visit www.modernatx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.